Your browser doesn't support javascript.
loading
Combined ARHGEF6 and Tumor Mutational Burden may serve as a potential biomarker for immunotherapy of lung adenocarcinoma.
Tong, Li; Wang, Sichu; Yang, Juanjuan; Zhang, Qing; Gu, Xue; Mo, Taoming; Luo, Yang; Zhang, Chenqian; Zhang, Jianguo; Liu, Yifei.
Afiliação
  • Tong L; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
  • Wang S; Dalian Medical University, Dalian, China.
  • Yang J; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
  • Zhang Q; Dalian Medical University, Dalian, China.
  • Gu X; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
  • Mo T; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
  • Luo Y; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
  • Zhang C; Medical School of Nantong University, Nantong, China.
  • Zhang J; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
  • Liu Y; Medical School of Nantong University, Nantong, China.
Heliyon ; 9(8): e18501, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37600416
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article